Friday, July 10, 2026

pharma · Moderate to severe systemic lupus erythematosus · Lupus Erythematosus, Systemic

Viatris Pharmaceuticals Co

Viatris Healthcare is a pharma organization headquartered in FR. Primary therapeutic focus areas include Moderate to severe systemic lupus erythematosus, Lupus Erythematosus, Systemic, Acute Myocardial Infarction, Stable

FR HQ
4 Employees
NMPA registrant Type
Company details
Status
Public
HQ
FR
Employees
4
Programs
8
Drugs
23
Patents
0
Clinical program

ID-064-108

Phase 1 · other · Not applicable - healthy volunteer trial

ID-064-108 for Not applicable - healthy volunteer trial is a Phase 1 program (other) at Viatris Pharmaceuticals Co., with 1 ClinicalTrials.gov record(s).

Internal code ID-064-108

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Viatris Pharmaceuticals Co.,
Phase
Phase 1
Modality
other
Indication
Not applicable - healthy volunteer trial
Status
active
Trials
1

Clinical trials